ARTICLE | Clinical News
MedImmune Inc. regulatory update
December 6, 1993 8:00 AM UTC
MedImmune Inc. (MEDI) MEDI's CytoGam received marketing approval in Turkey for the prevention of cytomegalovirus disease associated with kidney transplants. MEDI will distribute the polyclonal antibo...